CFTC Orders Kalshi to Halt 'Trump Mention' Markets — the Agency Restrains Its Own Protégé
The CFTC notified Kalshi that its 'mention' markets — contracts on what President Trump will say — are under a formal stay, forcing an indefinite pause pending a review of whether the contracts are 'readily susceptible to manipulation.' Kalshi has until December 11 to defend the products, and its CEO reportedly disagrees with the suspension. The action is notable because the CFTC has spent 2026 defending Kalshi against state enforcement; here the same agency is restricting one of Kalshi's own product lines, demonstrating that its role as the platforms' federal protector does not preclude it from policing specific contracts.
The CFTC notified Kalshi that its 'mention' markets — contracts on what President Trump will say, such as whether he will use particular words in a speech or appearance — are subject to a formal stay, forcing an indefinite pause on trading pending the agency's review. The CFTC is examining whether the contracts are 'readily susceptible to manipulation,' the statutory standard that allows the agency to prohibit an event contract. Kalshi has until approximately December 11 to defend the products to the agency, and the company's CEO reportedly disagrees with the suspension. Mention markets have been among the more contested contract categories on Kalshi: they were explicitly excluded from the company's proposed margin trading program and from the CFTC's October move to classify event contracts as swaps, reflecting a recognition that contracts on speech content occupy a different and more problematic category than economic or financial contracts.
The manipulation concern with mention markets is concrete and structural. A contract on whether a public figure will say a specific word or phrase can be influenced directly by that figure or by anyone with advance knowledge of a prepared speech. If a speechwriter, aide, or the speaker himself knows the content of an address before it is delivered, they possess material non-public information that moves the contract with certainty — and in the most direct case, the subject of the contract can simply choose to say or not say the word, determining the outcome at will. This is a form of manipulability that does not exist in contracts on exogenous events like economic data or election results, where no single participant controls the outcome. The 'readily susceptible to manipulation' standard exists precisely for contracts of this kind, and the CFTC's review will assess whether mention markets can satisfy it.
The more significant feature of the action is what it reveals about the CFTC's dual role. Throughout 2026, the CFTC has been the prediction market sector's principal federal defender: it has sued more than a dozen states, filed amicus briefs asserting exclusive jurisdiction, moved to classify event contracts as swaps, and directed the platforms to stop geofencing states. That record has led critics to characterize the agency, in the words of Louisiana's attorney general, as an 'obsequious standard bearer' for the platforms. The stay on Kalshi's mention markets complicates that characterization. Here the CFTC is exercising its regulatory authority against Kalshi, restricting a product the company wants to offer, on the same manipulation grounds that state regulators and the NFL have raised about prediction market contracts generally. The action demonstrates that the agency's defense of the platforms' jurisdiction is not the same as approval of every contract they list, and it gives the CFTC a concrete example to cite in response to the accusation that it is captured by the industry it regulates.
For Kalshi, the stay is a reminder that federal regulation carries obligations as well as protections. The company's entire legal strategy rests on the argument that CFTC oversight is adequate and that federal regulation is preferable to state gambling regulation. That argument is strongest when the CFTC is visibly exercising genuine oversight — which the mention-markets stay demonstrates — but it also means Kalshi must accept the CFTC's authority to restrict its products, including popular and high-volume ones. Mention markets on political figures' statements have been a distinctive and heavily-marketed Kalshi offering, and the indefinite pause removes a category that generated both volume and attention. The December 11 deadline for Kalshi to defend the contracts sits alongside the other December milestones converging on the sector: the CFTC's geofencing compliance deadline around December 5, Kalshi's Supreme Court response brief due December 7, and the Louisiana preliminary injunction hearing on November 30. The mention-markets review adds the question of which specific contracts the CFTC will actually permit to the larger question of whether the platforms can operate at all.
Operators mentioned in this article
Recent updates
Fourth Circuit Rules Against Kalshi in Maryland — Circuit Split Widens to 3-1 With a Notable Dissent
A divided Fourth Circuit panel ruled 2-1 on November 17 that Maryland gaming regulators can pursue enforcement against Kalshi over unlicensed sports betting, rejecting the platform's CFTC-preemption argument. Judge DeAndrea Benjamin dissented, arguing that Kalshi's sports event contracts are 'swaps' under exclusive CFTC oversight — the first appellate dissent on the pro-Kalshi side of the question. The ruling makes the Fourth Circuit the third appeals court to rule against Kalshi, deepening the split to three circuits against (Fourth, Sixth, Ninth) and one for (Third), with the Supreme Court cert petition pending.
CFTC and DOJ Sue Louisiana and Arkansas as Federal-State Fight Turns Openly Hostile
Louisiana Attorney General Liz Murrill won a temporary restraining order on November 12 against 31 prediction market entities, including Kalshi, Polymarket, Robinhood, and Coinbase, with a preliminary injunction hearing set for November 30. The CFTC — now joined by the Department of Justice — sued both Louisiana and Arkansas to block the state enforcement, marking Louisiana as the twelfth state the agency has taken to court. The dispute has turned personal: Murrill called CFTC Chairman Michael Selig an 'obsequious standard bearer' for the platforms, while Selig characterized her lawsuit as 'naked lawfare.' The DOJ's involvement escalates the federal response beyond the CFTC acting alone.
Kalshi and Polymarket Expand Into Health Contracts — Measles, Drug Trials, FDA Approvals Draw Scrutiny
Kalshi and Polymarket have added event contracts tied to US public health outcomes, including measles case-count thresholds settled using CDC data, clinical drug-trial results, and FDA regulatory approvals. Two Democratic senators wrote to the Department of Health and Human Services on November 11 raising concerns about the drug-trial and FDA markets, particularly the risk that people with confidential access to trial data or agency decisions could profit from disclosing it. Kalshi says it has implemented guardrails, such as limiting markets to late-stage trials. The expansion extends the debate over whether some prediction market categories commodify sensitive public outcomes in ways that create genuine harm.